Concepedia
Statistics
Publications
88
Citations
5.2K
H-Index
42
Active since
1986
Affiliations
Johns Hopkins University(Current)
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins Medicine
Albert Einstein College of Medicine
Children's Hospital at Montefiore
David M. Loeb is an author at Johns Hopkins University specializing in medicine, oncology, and molecular oncology.
Publications per year
1986–2024
Trk receptors use redundant signal transduction pathways involving SHC and PLC-γ1 to mediate NGF responses
Robert M. Stephens, David M. Loeb, Terry D. Copeland et al. · Neuron · 1994 · 540 citations · Full text
Life Sciences, Molecular Biology, Neurobiology +17
The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines
David M. Loeb, Johnna Maragos, Dionisio Martı́n-Zanca et al. · Cell · 1991 · 252 citations
Medicine, Cell Biology, Molecular Biology +11
Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation.
Ella Evron, Christopher B. Umbricht, Dorian Korz et al. · PubMed · 2001 · 213 citations
Life Sciences, Molecular Biology, Oncology +17
Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.
David M. Loeb, Ella Evron, Chirag B. Patel et al. · PubMed · 2001 · 211 citations
Life Sciences, Genetics, Oncology +17
Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells.
Victor P. Terranova, Erkki Hujanen, David M. Loeb et al. · Proceedings of the National Academy of Sciences · 1986 · 172 citations · Full text
Medicine, Cell Biology, Oncology +17
1–5 of 88